Novel insights into microbiome in colitis and colorectal cancer

Abstract excerpt

PURPOSE OF REVIEW: Microbiota is a major player in the pathogenesis of inflammatory bowel diseases (IBD) and colorectal cancer (CRC). Here, we summarize the key advances achieved in the past 18 months (ending June 2017) toward a better understanding of the role of microbiota in colitis and CRC development. RECENT FINDINGS: Accumulating evidence shows the essential role of intestinal barrier function (e.g. mucus,...

Topics

Join the communities discussing this publication.

• Clostridium difficile and Clostridium perfringens research
• Gut microbiota and health
• Probiotics and Fermented Foods